Collegium Pharmaceutical is growing our portfolio of differentiated medications to responsibly treat serious medical conditions, including moderate-to-severe pain. We are proud of our portfolio to support people living with pain, which includes internally developed and more recently acquired products, each of which represents meaningful innovation and, together, reflect our commitment to leadership in responsible pain management.